31 May 2022
TRIAN INVESTORS 1 LIMITED
(the "Company")
Investment in Unilever
Trian Investors Management, LLC (the "Investment Manager") recently informed the Company's Board of Directors that Trian Investors 1, L.P. (the "Investment Partnership"), together with other funds managed by Trian Fund Management, L.P. ("Trian"), hold interests in approximately 37.4 million ordinary shares of Unilever plc ("Unilever") (constituting approximately 1.5%* of Unilever's share capital). The Company, through the Investment Partnership, holds 1.06 million ordinary shares, which it acquired in April 2022 for $50 million (£37.7 million).
Earlier today, Unilever announced the appointment of Nelson Peltz as a Non-Executive Director of the company and a member of its Compensation Committee. It is expected that the appointments will be effective from 20 July 2022, subject to receipt of any required regulatory approvals. Nelson Peltz is the Chief Executive Officer and a Founding Partner of Trian, the Investment Manager's parent.
The Investment Manager has informed the Company's Board that it believes Unilever has significant potential and Trian looks forward to working collaboratively with Unilever's management and board to help drive the company's strategy, operations, sustainability, and shareholder value for the benefit of all stakeholders. The Company expects to share more information regarding its investment in Unilever at an appropriate time in the future.
*Based on Unilever's shares in issue (excluding treasury shares) on 30 May 2022.
LEI: 213800UQPHIQI5SPNG39
For further information, please contact:
Numis Securities Limited
(Joint corporate broker)
+44 (0)20 7260 1000
David Benda
Jefferies International Limited
(Joint corporate broker)
+44 (0)20 7029 8000
Stuart Klein
Ocorian Administration (Guernsey) Limited
(Administrator and Company Secretary)
+44 (0)1481 742 742
Chezi Hanford
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.